Abbott Laboratories (ABT)
110.48
+1.55
(+1.42%)
USD |
NYSE |
Sep 02, 16:00
110.63
+0.15
(+0.14%)
After-Hours: 19:41
Abbott Laboratories Research and Development Expense (TTM) : 3.128B for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.128B |
| March 31, 2026 | 2.954B |
| December 31, 2025 | 2.89B |
| September 30, 2025 | 2.897B |
| June 30, 2025 | 2.862B |
| March 31, 2025 | 2.841B |
| December 31, 2024 | 2.821B |
| September 30, 2024 | 2.783B |
| June 30, 2024 | 2.731B |
| March 31, 2024 | 2.744B |
| December 31, 2023 | 2.715B |
| September 30, 2023 | 2.716B |
| June 30, 2023 | 2.835B |
| March 31, 2023 | 2.809B |
| December 31, 2022 | 2.852B |
| September 30, 2022 | 2.919B |
| June 30, 2022 | 2.811B |
| March 31, 2022 | 2.781B |
| December 31, 2021 | 2.738B |
| September 30, 2021 | 2.678B |
| June 30, 2021 | 2.586B |
| March 31, 2021 | 2.496B |
| December 31, 2020 | 2.418B |
| September 30, 2020 | 2.295B |
| June 30, 2020 | 2.309B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.322B |
| December 31, 2019 | 2.416B |
| September 30, 2019 | 2.402B |
| June 30, 2019 | 2.381B |
| March 31, 2019 | 2.377B |
| December 31, 2018 | 2.288B |
| September 30, 2018 | 2.345B |
| June 30, 2018 | 2.265B |
| March 31, 2018 | 2.212B |
| December 31, 2017 | 2.172B |
| September 30, 2017 | 1.892B |
| June 30, 2017 | 1.735B |
| March 31, 2017 | 1.563B |
| December 31, 2016 | 1.358B |
| September 30, 2016 | 1.393B |
| June 30, 2016 | 1.397B |
| March 31, 2016 | 1.392B |
| December 31, 2015 | 1.369B |
| September 30, 2015 | 1.341B |
| June 30, 2015 | 1.306B |
| March 31, 2015 | 1.298B |
| December 31, 2014 | 1.331B |
| September 30, 2014 | 1.349B |
| June 30, 2014 | 1.401B |
| March 31, 2014 | 1.428B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Becton, Dickinson & Co. | 1.135B |
| Boston Scientific Corp. | 2.153B |
| DexCom, Inc. | 604.00M |
| Insulet Corp. | 345.90M |
| Intuitive Surgical, Inc. | 1.414B |